icon-    folder.gif   Conference Reports for NATAP  
 
  AIDS 2022
July 29 - Aug 2
24th Intl AIDS Conference
Back cgrey_arrow_rt.gif
 
 
 
Long-term Safety and Efficacy of
Emtricitabine/Tenofovir Alafenamide (F/TAF) With a
Third Agent in Children Living With HIV

 
 
  AIDS 2022 July 29-Aug 1 Montreal
 
Renate Strehlau,1 Jaime G. Deville,2 Chrisna Andersen,3 Elizabeth McFarland,4 Janet S. Chen,5 Shirley Li,6 Heather Maxwell,6 Vinicius A. Vieira,6 Kathryn Kersey,6 Elizabeth Castaño,7 Mark F. Cotton8
1Wits VIDA-Nkanyezi, University of the Witwatersrand, Johannesburg, South Africa; 2UCLA David Geffen School of Medicine, Los Angeles, California, USA; 3Be Part Yoluntu Centre, Paarl, South Africa; 4University of Colorado School of Medicine, Children’s Hospital Colorado, Aurora, USA;
5Drexel University College of Medicine, Philadelphia, Pennsylvania, USA; 6Gilead Sciences, Inc., Foster City, California; 7Hospital del Niño, Ciudad de Panama, Panama; 8Family Centre for Research with Ubuntu (FAMCRU), Stellenbosch University, Cape Town, South Africa

0806221copy

0806223copy

0806222copy

0806223copy

0806224copy

0806225copy

0806226copy

0806227copy

0806228copy

0806229copy